Refined genomic localization and ethnic differences observed for the IBD5 association with Crohn's disease

European Journal of Human Genetics

Volumn 15, Issue 3, 2007, Pages 328-335

  Silverberg, Mark S ^a   Duerr, Richard H ^b,c   Brant, Steven R ^d,e   Bromfield, Gillian ^f   Datta, Lisa W ^d,e   Jani, Niraj ^b   Kane, Sunanda V ^f   Rotter, Jerome I ^g   Schumm, L Philip ^f   Steinhart, A Hillary ^a   Taylor, Kent D ^g   Yang, Huiying ^g   Cho, Judy H ^f   Rioux, John D ^h   Daly, Mark J ⁱ  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^f UNIVERSITY OF CHICAGO   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h MONTREAL HEART INSTITUTE   (Canada)

ⁱ MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON REGULATORY FACTOR 1; ORGANIC CATION TRANSPORTER 1; ORGANIC CATION TRANSPORTER 2; OXYGENASE; PROPYL 4 HYDROXYLASE; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; CHROMOSOME 5Q; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; ETHNIC DIFFERENCE; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCATION; GENE LOCUS; GENE MAPPING; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; JEW; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PHENOTYPIC VARIATION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS; ULCERATIVE COLITIS;

EID: 33847212513     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5201756     Document Type: Article

References (37)

1. Podolsky DK: Inflammatory bowel disease. N Engl J Med 2002; 347: 417-429.
2. Guindi M, Riddell RH: Indeterminate colitis. J Clin Pathol 2004; 57: 1233-1244.
3. Rogler G: Update in inflammatory bowel disease pathogenesis. Curr Opin Gastroenterol 2004; 20: 311-317.
4. Tysk C, Lindberg E, Jarnerot G, Floderus-Myrhed B: Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins: A study of heritability and the influence of smoking. Gut 1988; 29: 990-996.
5. Thompson NP, Driscoll R, Pounder RE, Wakefield AJ: Genetics versus environment in inflammatory bowel disease: Results of a British twin study. BMJ 1996; 312: 95-96.
6. Subhani JMS, Ounder RE, Wakefield AJ: Concordance rates of twins and siblings in inflammatory bowel disease. Gut 1998; 42: A40.
7. Halfvarson J, Bodin L, Tysk C, Lindberg E, Jarnerot G: Inflammatory bowel disease in a Swedish twin cohort: A long-term follow-up of concordance and clinical characteristics. Gastroenterology 2003; 124: 1767-1773.
8. Orholm M, Munkholm P, Langholz E, Nielsen OH, Sorensen IA, Binder V: Familial occurrence of inflammatory bowel disease. N Engl J Med 1991; 324: 84-88.
9. Hugot JP, Laurent-Puig P, Gower-Rousseau C et al: Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 1996; 379: 821-823.
10. Satsangi J, Parkes M, Louis E et al: Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nat Genet 1996; 14: 199-202.
11. Hampe J, Schreiber S, Shaw SH et al: A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort. Am J Hum Genet 1999; 64: 808-816.
12. Ma Y, Ohmen JD, Li Z et al: A genome-wide search identifies potential new susceptibility loci for Crohn's disease. Inflamm Bowel Dis 1999; 5: 271-278.
13. Duerr RH, Barmada MM, Zhang L, Pfutzer R, Weeks DE: High-density genome scan in Crohn disease shows confirmed linkage to chromosome 14q11-12. Am J Hum Genet 2000; 66: 1857-1862.
14. Rioux JD, Silverberg MS, Daly MJ et al: Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am J Hum Genet 2000; 66: 1863-1870.
15. Hugot JP, Chamaillard M, Zouali H et al: Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411: 599-603.
16. Ogura Y, Bonen DK, Inohara N et al: A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001; 411: 603-606.
17. Economou M, Trikalinos TA, Loizou KT, Tsianos EV, Ioannidis JP: Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: A meta-analysis. Am J Gastroenterol 2004; 99: 2393-2404.
18. Inoue N, Tamura K, Kinouchi Y et al: Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology 2002; 123: 86-91.
19. Shifman S, Kuypers J, Kokoris M, Yakir B, Darvasi A: Linkage disequilibrium patterns of the human genome across populations. Hum Mol Genet 2003; 12: 771-776.
20. Sugimura K, Taylor KD, Lin YC et al: A novel NOD2/CARD15 haplotype conferring risk for Crohn disease in Ashkenazi Jews. Am J Hum Genet 2003; 72: 509-518.
21. Rioux JD, Daly MJ, Silverberg MS et al: Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn's disease. Nat Genet 2001; 29: 223-228.
22. Daly MJ, Rioux JD, Schaffner SF, Hudson TJ, Lander ES: High-resolution haplotype structure in the human genome. Nat Genet 2001; 29: 229-232.
23. Armuzzi A, Ahmad T, Ling KL et al: Genotype-phenotype analysis of the Crohn's disease susceptibility haplotype on chromosome Sq31. Gut 2003; 52: 1133-1139.
24. Giallourakis C, Stoll M, Miller K et al: IBD5 is a general risk factor for inflammatory bowel disease: Replication of association with Crohn disease and identification of a novel association with ulcerative colitis. Am J Hum Genet 2003; 73: 205-211.
25. McGovern DPB, van Heel DA, Negoro K, Ahmad T, Jewell DP: Further evidence of IBD5/CARD15 (NOD2) epistasis in the susceptibility to ulcerative colitis. Am J Hum Genet 2003; 73: 1465-1466.
26. Mirza MM, Fisher SA, King K et al: Genetic evidence for interaction of the 5q31 cytokine locus and the CARD15 gene in Crohn disease. Am J Hum Genet 2003; 72: 1018-1022.
27. Negoro K, McGovern DP, Kinouchi Y et al: Analysis of the IBD5 locus and potential gene-gene interactions in Crohn's disease. Gut 2003; 52: 541-546.
28. Torok HP, Glas J, Tonenchi L et al: Polymorphisms in the DLG5 and OCTN cation transporter genes in Crohn's disease. Gut 2005; 54: 1421-1427.
29. Peltekova VD, Wintle RF, Rubin LA et al: Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet 2004; 36: 471-475.
30. Noble CL, Nimmo ER, Drummond H et al: The contribution of OCTN1/2 variants within the IBD5 locus to disease susceptibility and severity in Crohn's disease. Gastroenterology 2005; 129: 1854-1864.
31. Newman B, Gu X, Wintle R et al: A risk haplotype in the solute carrier family 22A4/22A5 gene cluster influences phenotypic expression of Crohn's disease. Gastroenterology 2005; 128: 260-269.
32. Vermeire S, Pierik M, Hlavaty T et al: Association of organic cation transporter risk haplotype with perianal penetrating Crohn's disease but not with susceptibility to IBD. Gastroenterology 2005; 129: 1845-1853.
33. Waller S, Tremelling M, Bredin F, Godfrey L, Howson J, Parkes M: Evidence for association of OCTN genes and IBD5 with ulcerative colitis. Gut 2005; 55: 809-814.
34. Daly MJ, Rioux JD: New approaches to gene hunting in IBD. Inflamm Bowel Dis 2004; 10: 312-317.
35. Purcell S, Sham P, Daly MJ: Parental phenotypes in family-based association analysis. Am J Hum Genet 2005; 76: 249-259.
36. Palmieri O, Latiano A, Valvano R et al: Variants of OCTN1-2 cation transporter genes are associated with both Crohn's disease and ulcerative colitis. Aliment Pharmacol Ther 2006; 23: 497-506.
37. Vasiliauskas EA, Plevy SE, Landers CJ et al: Perinuclear anti-neutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroup. Gastroenterology 1996; 110: 1810-1819.